As the tumor benefits from the BDNF-mimicking effects of NAS, factors that increase the NAS/melatonin ratio, including the AhR, P2Y1r and mGluR5 become other direct and indirect targets of the tumor in its quest for survival. The gene discussed is BDNF; the disease is neoplasm.